Cu-67 Photonuclear Production

Journal Article · Wed Jun 01 00:00:00 EDT 2011 · AIP Conference Proceedings

DOI:https://doi.org/10.1063/1.3586150· OSTI ID:21513407

Starovoitova, Valeriia; Harris, Jason; Segebade, Christian R; Sinha, Vaibhav; Wells, Douglas P ^[1]; Foote, Davy ^[1]; Makarashvili, Vakhtang ^[1]

---

1. IdahoAccelerator Center, Idaho State University, 1500 Alvin Ricken Drive, Pocatello, ID 83201 (United States)

Cu-67 is considered as one of the most promising radioisotopes for cancer therapy with monoclonal antibodies. Current production schemes using high-flux reactors and cyclotrons do not meet potential market need. In this paper we discuss Cu-67 photonuclear production through the reaction Zn-68({gamma},p)Cu-67. Computer simulations were done together with experiments to study and optimize Cu-67 yield in natural Zn target. The data confirms that the photonuclear method has potential to produce large quantities of the isotope with sufficient purity to be used in medical field.

• OSTI ID: 21513407
• Journal Information: AIP Conference Proceedings, Vol. 1336, Issue 1; Conference: CAARI 2010: 21. International Conference on the Application of Accelerators in Research and Industry, Fort Worth, TX (United States), 8-13 Aug 2010; Other Information: DOI: 10.1063/1.3586150; (c) 2011 American Institute of Physics; ISSN 0094-243X
• Country of Publication: United States
• Language: English

Related Subjects

07 ISOTOPES AND RADIATION SOURCES
62 RADIOLOGY AND NUCLEAR MEDICINE
COMPUTERIZED SIMULATION
COPPER 67
CYCLOTRONS
IMPURITIES
ISOTOPE PRODUCTION
MONOCLONAL ANTIBODIES
NEOPLASMS
PHOTONUCLEAR REACTIONS
PROTON-EMISSION DECAY
THERAPY
ZINC 68 TARGET
ACCELERATORS
ANTIBODIES
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
COPPER ISOTOPES
CYCLIC ACCELERATORS
DAYS LIVING RADIOISOTOPES
DECAY
DISEASES
INTERMEDIATE MASS NUCLEI
ISOTOPES
MEDICINE
NUCLEAR DECAY
NUCLEAR REACTIONS
NUCLEI
ODD-EVEN NUCLEI
RADIOISOTOPES
SIMULATION
TARGETS